Skip to main content
Premium Trial:

Request an Annual Quote

Denator Inks Swiss Distribution Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swiss distribution company Bucher Biotec will sell and service Denator's heat inactivation technology, used in handling biosamples, in Switzerland under an exclusive agreement, Denator said today.

Denator's Stabilizor T1 technology is used to stabilize tissues and fluids from the moment the sample is taken, and to keep enzymes from degrading.

Used for protein and peptide analysis, the technology can enhance the reliability of data interpretation and can reveal proteins and peptides that might otherwise be lost or undetectable due to degradation, Sweden-based Denator said.